The Norman/Clayman Endocrine Institute announced that new patient referrals for thyroid, parathyroid and adrenal cancer tumor surgeries are at record levels. Surgery for endocrine tumors therefore appears pandemic-proof, while other hospitals fear for elective surgical delays due to the Covid delta variant surge.
Endocrine tumor surgery should not be delayed
by surge in Covid's Delta variant
With cases of COVID-19 surging in all 50
states and many foreign countries,
surgeons and hospitals with high volumes
of elective surgery are concerned that
patients will once again put off their knee
replacement or other procedure that isn’t
absolutely necessary.
"We aren’t seeing this at all. Patients with
thyroid, parathyroid, and adrenal tumors often
feel miserable, and they do not want to put off
an operation that will make them feel better,
and of course, they do not want to delay
having their thyroid cancer cured" says Dr Jim
Norman
The Norman/Clayman Endocrine
Institute in Tampa, FL announced
that new patient referrals for thyroid,
parathyroid and adrenal surgery
have reached an all-time high,
despite fears of another pandemic
spike.
This is in contrast to some other
forms of elective surgery, such
as knee and hip replacements,
which have not fully recovered
from the dramatic shut down of
2020.
The Norman/Clayman
Endocrine institute is the world’s
highest volume center for
surgery of thyroid, parathyroid
and adrenal tumors and
cancers.
The institute includes the
following specialty centers: The
Norman Parathyroid Center, the
Clayman Thyroid Cancer Center
and the Carling Adrenal Center.
“The patients are coming from all 50 states
and from 14 foreign countries in just the
past few weeks,” said Dr Norman. “These
are numbers we have never seen before,
showing that patients with endocrine
tumors are not going to wait like they were
forced to last year."
"The fear of delayed cancer surgery
potentially leading to lower cure rates and
more advanced disease has many patients
unwilling to put off endocrine surgery. “Many
patients operated on over the past 9 months
are frustrated and angry that their cancer
surgery was delayed”
“Endocrine surgery has two distinct
advantages over many other
operations that have been lumped
together under the term ‘elective’,"
continued Dr. Norman, who is the
CEO of the Norman/Clayman
Endocrine Institute.
"The first is the lack of need for overnight
stay in most cases, and the second is
that patients with endocrine tumors and
cancers won’t let their operations be
delayed again. They have learned their
lesson and they are quite vocal about it
online.”
Contact Us At:
parathyroid.com or call:
+1-813-972-0000
by surge in Covid's Delta variant
With cases of COVID-19 surging in all 50
states and many foreign countries,
surgeons and hospitals with high volumes
of elective surgery are concerned that
patients will once again put off their knee
replacement or other procedure that isn’t
absolutely necessary.
"We aren’t seeing this at all. Patients with
thyroid, parathyroid, and adrenal tumors often
feel miserable, and they do not want to put off
an operation that will make them feel better,
and of course, they do not want to delay
having their thyroid cancer cured" says Dr Jim
Norman
The Norman/Clayman Endocrine
Institute in Tampa, FL announced
that new patient referrals for thyroid,
parathyroid and adrenal surgery
have reached an all-time high,
despite fears of another pandemic
spike.
This is in contrast to some other
forms of elective surgery, such
as knee and hip replacements,
which have not fully recovered
from the dramatic shut down of
2020.
The Norman/Clayman
Endocrine institute is the world’s
highest volume center for
surgery of thyroid, parathyroid
and adrenal tumors and
cancers.
The institute includes the
following specialty centers: The
Norman Parathyroid Center, the
Clayman Thyroid Cancer Center
and the Carling Adrenal Center.
“The patients are coming from all 50 states
and from 14 foreign countries in just the
past few weeks,” said Dr Norman. “These
are numbers we have never seen before,
showing that patients with endocrine
tumors are not going to wait like they were
forced to last year."
"The fear of delayed cancer surgery
potentially leading to lower cure rates and
more advanced disease has many patients
unwilling to put off endocrine surgery. “Many
patients operated on over the past 9 months
are frustrated and angry that their cancer
surgery was delayed”
“Endocrine surgery has two distinct
advantages over many other
operations that have been lumped
together under the term ‘elective’,"
continued Dr. Norman, who is the
CEO of the Norman/Clayman
Endocrine Institute.
"The first is the lack of need for overnight
stay in most cases, and the second is
that patients with endocrine tumors and
cancers won’t let their operations be
delayed again. They have learned their
lesson and they are quite vocal about it
online.”
Contact Us At:
parathyroid.com or call:
+1-813-972-0000